Transient viral blips ≥20 copies/mL were observed in 16.9% of acutely treated adults with HIV. Blip incidence increased from 0.0 (95% CI, 0.0-2.9)/100 person-years after ART in Fiebig I to 15.9 (7.6-29.2) in Fiebig V. Increasing viral load and Fiebig stage at ART initiation were independently predictive of blips.
Keywords: Thailand; acquired immunodeficiency syndrome; anti-HIV agents; antiretroviral agents; viremia.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.